Banaz Jalil1*
Ivo Pischel1,2*
Björn Feistel3
Cynthia Suarez3*Andressa Blainski3
Ralf Spreemann3René Roth-Ehrang3
Michael Heinrich1,4*- 1Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, United Kingdom
- 2Dr. Ivo Pischel Consulting, Rossbach, Germany
- 3Finzelberg GmbH & Co. KG, Andernach, Germany
- 4Chinese Medicine Research Center, Department of Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taichung, Taiwan
Thymus serpyllum L. (Lamiaceae), known in English as ‘wild thyme’, is primarily found in the Palearctic realm (Eurasia, North Africa) and has been utilized traditionally for culinary, nutritional, medicinal, and aromatic purposes. The essential oil extracted from wild thyme is particularly noteworthy, being used extensively in the food industry as a flavoring agent and preservative. The plant’s aerial parts are commonly employed as an element of the diet (e.g., tea)/for culinary uses and in local/traditional medicine (primarily for managing respiratory and gastrointestinal conditions), similar to the use of common thyme. There is practically no information available on the species’ nutritional benefits. Pharmacological studies, including in vitro and in vivo research, alongside a limited number of clinical trials, have investigated extracts of Thymus serpyllum, although these extracts are often phytochemically poorly characterized in different experimental protocols and models. These studies have demonstrated a range of therapeutic effects, such as antimicrobial (notably the essential oil) and anti-inflammatory, as well as its preventative health benefits and nutritional value of wild thyme. Preclinical studies have corroborated the plant’s anti-inflammatory potential, particularly in conditions like inflammatory bowel diseases (IBD) and irritable bowel syndromes (IBS). Additionally, evidence of hepatoprotective activities and benefits in managing metabolic syndrome and cardiovascular health issues, such as lipid metabolism regulation, cholesterol reduction, antidiabetic, antihypertensive, and immunomodulatory effects, have been observed predominantly in rodent models. Phytochemical analysis of wild thyme reveals an essential oil fraction below 1%, along with non-volatile compounds predominantly comprising phenolic acids (such as rosmarinic, salvianolic, and caffeic acids) and flavonoids (mainly glucosides of luteolin, apigenin, and their derivatives). These components are believed to contribute significantly to the plant’s medicinal, nutritional, and preventive health properties. Despite promising findings, there is a need for more rigorously designed controlled clinical trials using phytochemically characterized wild thyme. The plant has an excellent safety and tolerability record. This review at the interface of nutritional/preventive health properties and as pharmacological activities highlights the current role of wild thyme in nutrition and general healthcare as well as its future potential, and also points to important gaps in the literature.
1 Introduction
Thymus serpyllum L. (Lamiaceae), commonly known as wild thyme, presents a compelling case study in the field of ethnobotany, nutrition and phytotherapy. This perennial herb thrives in the diverse climates of the Palearctic realm, although nowadays cultivated in many world regions for its aromatic essential oil or the herbal part used in food or as medicine in the food and pharmaceutical industry (1). So far, a limited number of reviews on Thymus serpyllum (T. serpyllum) have been conducted mainly on the characteristics and properties of the essential oil for its antimicrobial, antioxidants, and anti-inflammatory activities (2–4) whereas a monograph about the genus Thymus, including wild thyme, was published two decades ago (1). This review endeavors to unravel the complexities of wild thyme, providing an in-depth exploration of its botanical attributes, traditional applications, nutritional value, pharmacological potential, and safety aspects.
The cultural and historical context of wild thyme is as rich and varied as its pharmacological portfolio. Traditionally appreciated for its role in herbal teas and as a culinary enhancer, particularly for its aromatic essential oil, T. serpyllum has long been a staple in various regional cuisines and medicinal practices (1). The use of its aerial parts in traditional medicine, especially for respiratory and gastrointestinal complaints, underscores its significance in ethnomedicine.
In recent years, the scientific inquiry has shifted toward understanding the phytochemical composition of wild thyme. The presence of essential oils, phenolic acids, and flavonoids in the plant points to potentially complex phytochemical synergies underpinning its preventive health benefits and therapeutic properties (1). These compounds have been the focus of various in-vitro and in-vivo studies, along with clinical trials, which collectively suggest promising antimicrobial, anti-inflammatory, hepatoprotective, and cardio-metabolic effects. The plant’s benefits in managing conditions like inflammatory bowel diseases and irritable bowel syndromes, as well as its positive impact on the gut-brain axis and the gut microbiome, are particularly noteworthy.
Despite its established traditional use and emerging scientific backing, there remains a gap in the form of well-designed controlled clinical trials. This review aims to highlight the importance of such studies to further assess the safety, nutritional value, and efficacy of T. serpyllum. By bridging traditional knowledge with scientific research, this review seeks to contribute to understanding wild thyme’s role in modern herbal medicine and stimulate further research in this promising field.
2 Methodology
2.1 Search strategy
A systematic literature search was performed according to the PRISMA guidelines (5). The main databases included were Web of Science (core collection), PubMed, Scopus, and ScienceDirect, covering the period from the inception to December 2023. Articles published in several languages, mainly English, French, and German (i.e., articles without country or language restrictions), were reviewed. The terms searched with their combinations were Thymus serpyllum, wild thyme, chemical constituents, phytochemistry, biological activity, nutrition, pharmacology, toxicology, phytopharmacology, and traditional use. Additional information was retrieved by manually searching the studies and review articles. All articles were then exported to Rayyan software for review and evaluation. The workflow of the search strategy is shown in Figure 1. In addition, to understand the role of T. serpyllum in modern functional food and dietary supplement markets, we conducted a comprehensive search of relevant sub-categories through the Mintel database. Specifically, the search covered “Sugar & Gum Confectionery” and “Sauces & Seasonings” as well as “Personal Insect Treatment/Repellents,” “Decongestants, Cough, Cold & Flu Relief” and “Vitamins & Dietary Supplements.” The search yielded a total of 65 hits, indicating the growing interest in and use of T. serpyllum in various consumer product categories.
Figure 1. Workflow chart for inclusion and exclusion of studies in the systematic review using PRISMA model (5).
2.2 Study selection criteria
The literature search was conducted by two of the authors (BJ, IP), and next, the identified titles, abstracts and studies were evaluated, with any differences resolved through discussions among the authors of this review. The inclusion criteria that the review focuses on T. serpyllum L., including its chemistry, nutrition, pharmacology, toxicology and clinical assessment, with clear evidence that T. serpyllum and no other species of the genus were used. The studies, including the experimental approaches, phytochemical characterization and reporting of the plant materials and their initial processing, were assessed and evaluated following Heinrich et al. (6); Heinrich et al. (7). Specifically, the extracts/extraction process, dosage, control, and experimental models, including methodological details and reported outcomes were assessed (Supplementary Tables S2, S3). Studies using chemical antioxidant assays with claims about pharmacological activity were excluded since there is no evidence for therapeutic benefits on the basis of such chemical assays and many journals, e.g., in the field of food sciences and pharmacology, no longer accept them as relevant assays but only for chemical-analytical purposes (6).
2.3 Patent search strategy
A systematic patent search was performed by two of the authors (BF, IP) in several patent databases, including Espacenet, USPTO, Google Patents and Orbit.com. Two different search strategies were used, using different search terms, strings and several filters. The four patent databases used are FAMPAT: https://orbit.com/; GOOGLE PATENTS: https://patents.google.com/; ESPACENET: https://worldwide.espacenet.com/patent/search; USPTO: https://ppubs.uspto.gov/pubwebapp/. In the first strategy, the commercial Orbit’s patent database Fampat (The Fampat Collection; orbit.com) was used. Fampat combines results from “EP and PCT publications and links between US provisional and published applications” within a database-specific search strategy and language to search specifically for certain patent classes. Here, the important patent class – the IPC A61 patent class and all subclasses for ‘Medical and Veterinary Science, Hygiene’ use – including medicinal teas – was applied. Furthermore, only ‘thymi’ and ‘serpylli’ were used, which automatically includes translations such as thyme or thymus or serpyl or serpolet were used. This query returned 71 hits, five of which are relevant in the scope of this review (Supplementary Table S1).
In the second arm of our strategy, the open access patent databases Google Patents, Espacenet and USPTO were used. The main search term was “thymus serpyllum” combined with specific classification categories (IPC a/o CPC), e. g.: A61K36/53: IPC for Lamiaceae, A61K2236/30: IPC for extract/ion, and A23F3/16: IPC class for Tea extraction; Tea extracts; Treating tea extract; preparation of instant tea. This approach eventually resulted in a reasonable number of hits, less than 100, which were evaluated in more detail. After checking for country-specific multiple entries, the duplicates were removed. Concerning relevance, ten documents remained (see Table 1; Supplementary Table S1).
Table 1. Patent details of the relevant T. serpyllum patents, ordered by priority date (for granted patents the patent number is in bold).
3 Results and discussions
3.1 Botanical description and morphology
Wild thyme is an evergreen, ground-covering subshrub that reaches heights of 2 to 10 cm. It is forming a mat with closely prostate runners, which become woody (8). These lying stems are long, creeping, continue to grow for years and usually end with a tuft of leaves, rarely with an inflorescence. The branches are always hairy all around. The leaves are linear to narrowly elliptical or obovate, 3 to 10 mm long, 1 to 3 mm wide and short-stalked or sessile. The flower shoots hardly differ in size and shape. The uppermost pair of lateral nerves is usually lost and does not unite to form a peripheral nerve. The leaf blade is ciliated in the lower third, as is the petiole. The blade is rarely hairy. Their lateral nerves are blunt on the underside. The flowering period is from July to September. The inflorescence is capitate, faintly aromatic when fresh (8). The hermaphrodite flowers are zygomorphic and fivefold with a double perianth. The calyx is about 3.5 to 4.5 mm long, hairy below and glabrous above and imperforate at the teeth. The upper calyx teeth are broadly triangular and about as long as they are wide at the base (8, 9). The cytology reveals that the diploidic number of chromosomes is 2n = 24 (8, 9) (Figure 2).
Figure 2. Botanical drawing (top) and flowering wild thyme (bottom) of Thymus serpyllum (10), licenses acquired of botanical drawing (top) by Alamy (11), and flowering wild thyme (bottom) by 123RF (12).
3.1.1 Botanical name, etymology of the plant name, and common names in various languages
The botanical binomial name of wild thyme is Thymus serpyllum L., with many botanical synonyms due to numerous descriptions of several authors depending on different regions and occurrences of the plant. Many synonyms are tabularly compiled in the literature and databases (13). Different literature sources give reasonable explanations for the etymology of plant names “thymus” and “serpyllum.” For the genus name “Thymus,” there seem to be two possible ancient Greek origins: 1. θύμον (thúmon) from θύω (thúō, “to smoke”) (14) or θῡμῐ́ᾱμᾰ (thūmíāma), meaning “that which is burnt as incense or fumigation” for its fragrance, likely because of its use in religious celebrations or temple services. The latter is at least described several times in Herodotus’ Histories (15). Secondly, the word could stem from thumos, which means “courage or strength” (16), where thyme symbolized bravery, perhaps due to the refreshing and powerful scent of wild thyme, although confusingly “thymos” (lat. Thymus) also refers to the thymus gland. The descriptive specific epithet (species name) “serpyllum” is also of Greek origin ἕρπυλλος (hérpullos), from ἕρπω (hérpō, “to creep, crawl”), thus, meaning “creeping.” In Latin, it became serpere, i.e., “to creep.” Wild thyme is also called Creeping Thyme (17). Based upon this Greek/Latin origin, various regional names, botanical synonyms and common names in different languages derived. Thus, the English name is wild or creeping thyme, mother of thyme, Breckland thyme; the German name is Quendel, Sand-/Feldthymian; in French Serpolet, Italian Serpillo, Spanish Tomillo silvestre/serpoleto, Portuguese Serpão, Tomilho serpão/selvagem, Polish Macierzanka piaskowa, Serbic Душичка, Мајчина душица, Материна душица/Dušička, Majčina dušica, Materina dušica, Bulgarian Мащерка дива/Masherka diva, Swedish Backtimjan, Hindi: Banajwain, Chinese: 蒙百里香, Japanese: ボウシュウボク, Korean: 세르필룸백리향, whereas the (Phyto)Pharmaceutical terms are: Herba Thymi serpylli, Herba serpyllum, Serpylli herba (18).
3.2 Ecology and cultivation
3.2.1 Maps of global and world distribution of Thymus serpyllum
Thymus serpyllum and closely related taxa originated in the wider European, North African and Asian (Palearctic) region and have been introduced and distributed globally in regions with a suitable climate. It is cultivated in many world regions for its aromatic essential oil or the herbal part used in food or as medicine in the pharmaceutical industry. Some publications even indicate a broader distribution than shown on the map. On the other hand, some dots represent only a local occurrence in a botanical garden or alike (Figure 3) (19).
Figure 3. Global map of distribution of Thymus serpyllum (19). The area highlighted is the approximate native range of the species and it is now cultivated in a wide region in the Holarctic.
3.2.2 Cultivation and propagation
Wild thyme, a hardy (up to −15°C. minimum temperature) evergreen shrub, grows up to 0.1 m–0.3 m at a medium rate, flowering from July to August, with the seeds ripening from August to September. The seeds are used for reproduction mostly in late spring after the frost period, early or during summer. Germination is possible using surface sow or barely covered seeds. T. serpyllum is a hermaphrodite pollinated by insects. The plant prefers light, well-drained, relatively dry, generally sandy soil resulting in sand thyme as one common name. It tolerates a wide pH range from mildly acid and neutral to basic or mildly alkaline and likes calcareous soil but not so much salty conditions, although it can grow on sand dunes, it can withstand strong winds and droughts and prefers sunny exposures (20). The cultivation techniques are similar to other, more erect, thyme species, like common thyme, an exception of harvesting needs to be mentioned. Wild thyme is a creeping species that requires a more complex harvesting method (21). Chauhan et al. (22) describe a field experiment focusing on the effect of four different harvesting times (115 to 175 days after planting) on growth, yield and quality, especially of essential oil of wild thyme in Uttarakhand, India. During the four harvests, about 9 L/ha, each oil from dried aerial parts with contents between 0.5–0.7% were obtained (22). Heeger (23) quoted the Roman agronomist Palladius’ Treatise on Agriculture (Opus agriculturae) in the fifth century, whereas he only describes its planting as an Annex to his T. vulgaris chapter.
3.3 Economic botany and uses
The popularity of Mediterranean cuisine and the perceived health benefits of thyme are contributing to the growing demand for dried thyme in the European market. European production of dried thyme is not self-sufficient. The leading EU producers are Poland, followed by Spain and France, but large volumes are imported from non-European countries (24). Europe is the largest dried thyme importer in the world, accounting for a 50% share of the world’s total imports. Germany is the largest dried thyme importer in Europe, followed by Spain, Belgium, the United Kingdom, France, and the Netherlands. Around one-third of European dried thyme imports come from North Africa (Morocco and Egypt), Turkey, the Middle East (Israel and Syria), and the Balkans (Albania) (24). A significant share of imported dried thyme is used as a medical herb for the preparation of herbal teas and infusions. Thyme is also used as an ingredient in spice mixes for the food industry, including the potato and sausage industries. The increasing interest in international ethnic cuisines, combined with buyers’ needs for stable and sustainable sourcing, is the leading driving force behind the growing interest in dried thyme in Europe in fair-trade and organic-certified quality (24).
3.3.1 Traditional culinary use
Thymus vulgaris L. and T. serpyllum L. grow in the same areas (Europe and North Africa) and they have been used since ancient times as seasoning. Although several hundred species and cultivars are grown, among others, the best known are T. vulgaris and T. serpyllum (25). In East Europe, wild thyme is used in traditional dishes, for instance, in Moldova. Here, wild thyme is an important ingredient to prepare sour borscht (borș) with health-promoting qualities, obtained by fermenting wheat bran. This sour liquid food preparation is rather unknown to the Western but very popular in Eastern countries, e.g., the post-Soviet world. Wild thyme is inevitable for the traditional Moldovan soup called zeama. Also, T. serpyllum is used to flavor iron wine, oil or vinegar, whereas the herb with inflorescences, stems, and leaves are used to make tea (26). Wild thyme-flavored spirits are available as well, like the French digestive “Serpolette 25.6% Vol.,” a wild thyme liqueur produced by a company called MAISON 16.
3.3.2 Functional foods and dietary supplements
Thymus serpyllum is gaining significant traction in the functional food and dietary supplement markets. This trend is in line with the growing consumer preference for natural and herbal remedies. While T. serpyllum is best known for its traditional use in managing and treating respiratory conditions, its incorporation into various product categories has expanded its reach. T. serpyllum is often found as a key ingredient in medicinal confectionery products, including throat lozenges and pastilles. These products often target cold symptoms, cough suppression, and throat soothing. Well-known manufacturers have capitalized on this trend. T. serpyllum is also found in dietary supplements formulated to support respiratory health. These supplements typically contain a blend of herbs associated with respiratory health. Beyond its medicinal uses, T. serpyllum is occasionally included in functional foods and beverages for its aromatic properties, contributing to flavor profiles while offering potential health benefits.
Thymus serpyllum is rarely found as a mono-ingredient dietary supplement. Instead, it is often combined with a blend of complementary herbs traditionally associated with cold symptoms and respiratory health. However, an exception to this trend is a liquid product in the USA, which offers T. serpyllum as a standalone herbal supplement with no specific indications, serving a niche market segment.
The products are produced mainly in EU countries like Germany, Switzerland, Italy, and the USA. In total, 57 products were found in the Mintel Database. Herbs grown in the Mediterranean climate, including wild thyme, are part of the Mediterranean diet. Several studies suggest that a Mediterranean diet could lead to lowering the risk of cardiovascular diseases, neurodegenerative diseases, diabetes, and early death. Currently, industries around the world are following this trend, and they are offering dietary supplements with digestive & detoxifying treatments, including wild thyme as an ingredient (Figure 4).
Figure 4. Selection of Central and East European Thymus serpyllum (including combination) products (Photo Bjoern Feistel, 2023).
3.3.3 Traditional medicinal use
Serpylli herba, a well-documented and widely utilized herbal remedy, has enjoyed historical usage in the management of mild gastrointestinal and dyspeptic conditions. While there is currently no official monograph from the HMPC (Herbal Medicinal Products Committee), or as Hagers Enzyklopädie der Arzneistoffe und Drogen (27), the British Herbal Compendium (28), Herbal drugs (29) and Kooperation Phytopharmaka (30), provide information on wild thyme, including recommended dosage and indications. A Commission E monograph (1987; 1990) (31), specifically addresses wild thyme’s application in treating upper respiratory tract catarrhs. The extensive documentation supports the safe use of wild thyme, with no known contraindications, adverse effects, or interactions with other medications. Furthermore, an ESCOP (European Scientific Cooperative on Phytotherapy) monograph (32) on Serpylli herba documents the safe oral utilization of wild thyme, confirming the absence of interactions, undesirable effects, overdosing, and contraindications. Quality monographs found in several pharmacopoeias also highlight the widespread use of T. serpyllum, including traditional usage. These pharmacopoeias include Farmacopoea Official Española (33), DAB (Deutsches Arzneibuch) (34), Farmacopeia Portuguesa (35), Farmacopea Polska (35), Pharmacopoeia Hungarica (36), British Herbal Pharmacopoeia (37), Pharmacopée Française (38), and Pharmacopoeia European (39). In various European countries, finished medicinal products in the form of teas are available in the market. Dosage recommendations vary but can extend up to 9 grams of herbal drug equivalents per day. Additionally, products using extract preparations, either in aqueous or hydroethanolic form, presented in syrups, have also been identified. Wild thyme can be used in the preparation of herbal baths and herbal pillows (1, 40).
3.3.4 Cosmetics and skin care
Thyme oil is commonly incorporated in a variety of cosmetic products, including deodorants, due to its ability to neutralize odors and its antimicrobial characteristics (1, 41, 42). In soap fragrances, its robust and refreshing qualities add a touch of medicinal-like aroma, which is often preferred in specific soap or detergent types. Thyme oil is effective in concealing strong, tar-like smells (43).
When used sparingly in lotions, perfumes, or colognes, thyme oil contributes to a fuller, subtly sweet scent. Consequently, it is a component in the formulation of various cosmetic creams, lotions, eau-de-colognes (often blended with lemon and bergamot), and soap-based solutions for sterilizing surgeons’ hands (44). These products are beneficial in treating acne and other skin issues. Both thyme essential oil and thymol find applications in the production of toothpaste and mouth rinses (45, 46). A 10 percent peroxidised thyme oil solution in soap effectively eliminates oral microbial flora within three minutes (1, 40). Wild thyme is found as an extract in the cosmetic industry. It is recommended for sensitive skin, against itching, and for decongesting the scalp hair as an antiseptic and stimulant of the local blood flow (WILD THYME Liquid B, ICHIMARU PHARCOS CO., LTD. INCI Name: T. serpyllum Extract). The beneficial action on the microcirculation is associated with claims related to tired legs relief by protecting the micro capillaries from diverse deterioration and, in this way, facilitates the return of blood flow by maintaining vascular integrity (Tired Legs Complex, Greentech, INCI Name: Aqua (and) Propylene Glycol (and) T. serpyllum Extract (and) Ruscus aculeatus L. Root Extract). Another product is based on the traditional therapeutic use of wild thyme for wound treatment, general metabolism support and as a ‘fountain of youth’. The plant has a firming effect and is said to help with inflammatory changes in the skin. In this cosmetic product, wild thyme is in combination with lady’s mantle (Achillea spp.) and jujube (Ziziphus jujuba MILL.), which provides anti-aging, astringent and moisturizing effects for skin care preparations. Another application in the cosmetic industry for wild thyme is as a whitening agent. Wild Thyme prevents pigmentation by inhibiting the transport of melanin to epidermal cells. Wild thyme can also improve the appearance, texture and fragrance of cosmetic products (47).
3.3.5 Technological application and other uses
In addition to culinary and pharmaceutical uses of T. serpyllum preparations, there are several others, such as food preservation, especially for meat, milk, fish and their products or dishes (48) due to the antioxidant action or as an insect repellent or pesticide (49). The latter rely mainly on essential oils with main constituents like thymol or carvacrol (50) but sometimes also non-volatile extracts based on the rather high content of rosmarinic acid or di- and triterpenoids (51).
3.4 Regulatory aspects worldwide
The medicinal properties and the traditional use of T. serpyllum are recognized in several countries. In 2014, the European Scientific Cooperative on Phytotherapy (ESCOP) published a monograph described T. serpyllum for the treatment of upper respiratory tract catarrh as a bath additive to support acute or chronic diseases of the respiratory tract (32). These uses are based on evidence from long-term human use. In 1987 (revised 1990), the German Commission E published a monograph on the cut herb for infusions and other preparations for internal use and for the treatment of catarrh of the upper respiratory tract Commission E monograph (1987; 1990) (31).
Although there is a long tradition of medicinal use in Europe, the Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency has not established a harmonized monograph for therapeutic uses and conditions of safety, neither for well-established nor for traditional uses (52). However, there is a quality monograph in the European Pharmacopoeia describing the whole or cut, dried, flowering aerial parts of T. serpyllum L. with a requirement for essential oil of a minimum of at least 3.0 mL/kg in the dried drug (53).
In addition to its medicinal uses, T. serpyllum is used as food, as a culinary spice, or as tea, and also as a food supplement. T. serpyllum is included in several positive lists in European countries for the use in food supplements, such as Belgium (54), Croatia (55), France (56), Germany (57) and Italy, where health claims are established for digestive function, regulation of gastrointestinal motility and gas elimination, antioxidant, the well-being of the nose and throat (58). According to the EU Regulation 1924/2006, nutrition and health claims can be made on foods once they have been approved by the European Food Safety Authority (EFSA). However, more than 2000 applications for health claims on botanicals have not been evaluated by EFSA due to concerns raised by several EU member states and industry stakeholders about the different regulatory regimes for health claims in food and food supplements on the one hand and traditional herbal medicinal products on the other. However, these so-called “on-hold claims” can still be used to inform the consumer. For T. serpyllum, there are “on-hold claims” for respiratory (soothing for mouth and throat; ID 3716 and 4,166) and gastrointestinal health (improvement of digestive function; ID 4491) for being used in supplements. The combination of T. serpyllum with other plants is also used for respiratory health claims (ID 4607 and 4,615) (59). On the other hand, the benefits for the urinary system were considered inappropriate as they are general and do not refer to a specific health claim as required by Regulation (EC) No 1924/2006 (60). In Asian countries, T. serpyllum is also recognized as a food ingredient. Buds and leaves of T. serpyllum are recognized as Spices and Condiments in China (61). In addition, aqueous extracts of edible plants may be considered as food ingredients for the Botanical Beverages (62). In South Korea, T. serpyllum is listed in Annex I, “Ingredients Approved for Use in Food” in Food Code (63), which also states that food may be extracted using only water, alcohol, or a mixture of water and alcohol, and carbon dioxide. In Japan, this species is listed on the List of ingredient essences (raw materials) that are not considered pharmaceuticals unless they are labeled as having medicinal effects (64), and its water and ethanolic extracts can still be considered food or food additives. In India, the species is listed in the regulations of the Food Safety and Standards (FSSAI) (65). In the USA, the species is listed in Herbs of Commerce (66), and is recognized as safe for use as a spice and other natural seasonings and flavorings. Its aqueous and ethanolic extracts could commonly be available as a dietary supplement. In addition, T. serpyllum and it extracts, and based on the Food and Drug Administration (FDA) (67), and the essential oil is recognized as safe (GRAS) (68).
3.5 Patents and intellectual property rights (IPR)
Our search strategy resulted in a list of 15 patents. However, many of these documents show the main term “Thymus serpyllum” only as a botanical drug within a long list of plant species (see Supplementary Table S1).
After a successful patent examination procedure, only four of the 15 patent applications were finally granted as patents (indicated by the code “B” at the end of the patent number): RO98315B1, RO98319B1, US11179430B2, CN106344648B. The majority of the patent applications still show T. serpyllum only in a long plant list citation but without their own specific data. For example, only one patent is highly relevant because “Thymus serpyllum” (or Mother of Thyme) is mentioned in the title, abstract, claims, and the main text body of the document (Pat#6: US11179430B2 = WO2013182709A1), which deals only with T. serpyllum extracts, their preparation, and specific use/application (Table 1).
3.6 Phytochemistry
3.6.1 Nutritional value
The nutritional composition of T. serpyllum herba varies between literature sources and studies, probably due to different varieties, genetic, environmental, ecology and harvest conditions of the plant, as well as the analytical methodology (69) reported that T. serpyllum herba from India on dry weight bases contains protein (21.4 g/100 g), fat (5.5 g/100 g), carbohydrates (11.9 g/100 g), starch (6.5 g/100 g) and amino acids (2 g/100 g). The dietary fiber composition of wild thyme herba includes neutral detergent fiber (NDF) (15.1/100 g), acid detergent fiber (ADF) (10.6 g/100 g), lignin (3.6 g/100 g), hemicellulose (4.2 g/100 g) and cellulose (7.1 g/100 g). Vitamins (mg/100 g) are for Vitamin A 4.9, Vitamin C 43.8 and Vitamin E 13.7. Other bioactive metabolites are (Poly)Phenols (86.6 mg/g), Flavonoids (51.9 mg/g), and Phytosterols (45.3 mg/g). Some of the latter contribute to the antioxidant profile of T. serpyllum, measured/determined as DPPH (48.58 μg/mL) and FRAP (105 mg/g), which provides analytical-chemical guidance only. The ash content was found to be (2.7 g/100 g) and comprised of the following macro, micro minerals and non-metal elements quantified by e. g., X-Ray Fluorescence (XRF) analysis of the plant powder and other methods, like AAS, AES (Table 2). Some studies indicate that T. serpyllum can accumulate trace elements and heavy metals, like lead (Pb), if the soil is contaminated (69–72) (Table 2).
3.6.2 Bioactive metabolites
Wild thyme, as an aromatic member of the mint family, contains up to 1% essential oil, representing only a small fraction of the metabolites elucidated to date. Still, the essential oil’s composition and bioactivity have been studied much more extensively than the non-volatiles. An increasing number of metabolites have been elucidated over the last decades. For example, in the early 1990s, Duke (73) listed in his “Handbook of phytochemical constituents of GRAS herbs” 47 metabolites, of which 36 were essential oil compounds and 11 were non-volatile ones. On the other hand, a recent publication by Yang et al. (74) describes 410 metabolites of T. serpyllum, of which about 200 are flavonoids, followed by more than 120 phenolic acids. The detection of this large quantity of phytochemicals was possible by applying modern analytical instrumentation such as UPLC-ESI-Q TRAP-MS/MS coupling joint with a suitable data interpretation which also the most recent approach for species authentications and differentiation from other thymus species. Several similar publications failed to do so but reported wrong plant constituents, like silicon derivates and others, which obviously contaminants or artifacts. Many other publications focus more on essential oils and their compounds, although essential oils make up only about five permille of the dry raw material.
3.6.2.1 Essential oils of Thymus serpyllum
ESCOP (32) states the essential oil content of T. serpyllum with 0.1–0.6%, thus the single constituents within this group are minor ones, but due to the ease of separation by water steam distillation, they were characterized early in history. As mentioned above, about 35 volatile compounds, mainly terpenoids, are described, although additional new essential oil metabolites are occasionally reported due to advancements in analytical methods and techniques. Some authors analyzed the variability of the species T. serpyllum in one country (75), others even describe several chemotypes within a certain region (76). Steflitsch et al. (77) summarized about 15 main phytochemicals with their percental ranges, as shown in Table 3.
Table 3. Essential oils content of Thymus serpyllum.
3.6.2.2 Non-volatile metabolites of Thymus serpyllum
Depending on the region/origin, climate, time of harvest, extraction methods and solvents used, the following non-volatile plant constituents (e.g., Polyphenols, flavonoids, phenolic acids, and fatty acids) have been found and are summarized in Table 4.
Table 4. Non-volatile content of Thymus serpyllum.
High Performance Thin Layer Chromatography (HPTLC) analysis was applied for the separation of phytochemicals of T. serpyllum (methanolic extract) in comparison to T. vulgaris/zygis according to the method as described by Meier (79). This methodology could be used to authenticate T. serpyllum raw materials from the other thyme species. In this method, as shown, the two thyme species can be differentiated by their specific pattern of HPTLC bands after development and visualization, as seen in Figure 5.
Figure 5. HPTLC image of differentiation of Thymus serpyllum from Thymus vulgaris/zygis (79), used in the Standard Operation Procedure (SOP) for methanolic extracts including T. serpyllum and T. vulgaris by Finzelberg, Germany (Finzelberg-SOP-No. 5551). T. serpyllum (two lots in the 2 left lanes) and T. vulgaris/zygis (two lots in the 2 right lanes) plus reference substance rosmarinic acid in the middle lane; after derivatization and heating in UV-light at 365 nm.
In some cases, particularly for non-regulated commercial products, the presence of other Thymus species instead of T. serpyllum cannot be complete, considering its presence in spontaneous flora of various countries and its citation as rare or uncertain. It is impossible to assess this in any review, and also calls for better documentation of what is being studied. In addition, the difference in pharmacopoeial regulations regarding Serpylli herba and its origins may contribute to this confusion, including several national pharmacopoeias recommending the substitution with the aerial parts of other spontaneous Thymus species. On the other hand, official pharmacopoeias mainly regulate the use of pharmaceuticals thus the correct species labeling of the pharmaceutical products is required by law, with not strictly applied to non-regulated pharmaceutical products, like food or dietary supplements, hence, a confusion of T. serpyllum with other thymus species cannot be excluded, especially if they are labeled only thyme or wild thyme, because a number of different plants can be meant. At the same time there is also no control over the quality level of starting material used.
3.7 Biological and pharmacological activities
3.7.1 In-vitro studies
3.7.1.1 Antimicrobial activity
Many essential oils exhibit antibacterial and antiviral activities in various in-vitro models. These oils have been tested against pathogenic and non-pathogenic organisms. Several studies assessed the antimicrobial activity of T. serpyllum essential oils individually (76, 91–96) or in a mixture design enriched with other components including with other essential oils (92, 97, 98) using, for example, different bioassays, agar well/disk diffusion, broth dilution methods including determining the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC). In these studies, the tested concentrations varied between 5–15 μL showed activity against a broad spectrum of microorganisms with T. serpyllum essential oils. For example, the antibacterial activity with MIC (0.0625; 0.125% v/v) against Escherichia coli and Staphylococcus aureus (97), MIC (0.012–0.2%) and MBC (0.012–0.2%) (99) were studied. The strain of Pseudomonas aeruginosa showed slightly more sensitivity to T. vulgaris and T. serpyllum essential oils (MIC 0.5 mg/mL) (100). The antimicrobial activity against a broad spectrum of microorganisms was attributed to the high content of aromatic monoterpenoids thymol (95). In a different study, T. serpyllum essential oil in the range of concentration showed MIC/MBC (3.125–6.25/12.5 μL/mL) levels for gram-negative bacterial strain (102). T. serpyllum showed antimicrobial activity against oral pathogens, with the possible use for oral care (103), with the MIC (2.5–5 μg/mL), and MBC (5–10 μg/mL) for bacteria and MIC (1–2 μg/mL), and MFC (2–4 μg/mL) for fungi (93). The plant population of T. serpyllum, located in sunny meadow conditions, could have a significant content of the aromatic monoterpenes carvacrol and p-cymene, and has shown to have a wider spectrum of antimicrobial activity (76).
The secondary essential oils (hydrosolic essential oil fraction) of T. serpyllum were also found to have stronger antibacterial and antifungal activities, and they were richer in phenolic compounds (92.3%) compared to their content in primary essential oils (water insoluble essential oil fraction after steam-distillation) (42.1%) (104). N-Propyl rosmarinate, an isolate from T. serpyllum, showed the most potent antibacterial activity compared to other isolates (105). T. serpyllum essential oil in the vapor phase also showed antibacterial activity (33–350 μL/L); however, it was less effective compared to other investigated essential oils in the study (106).
The ethanol and chloroform extract of T. serpyllum were investigated in a number of in-vitro assays for their antibacterial activities (81, 91, 107–110). An ultrasonic 70% ethanolic extract of T. serpyllum in a concentration range of 0.0625 to 20 mg/mL showed bactericidal or bacteriostatic activity against a range of tested bacteria and fungi. However, there is a difference in the strength of action against strains of microorganisms (81), and the ethanolic extract was considered equally effective against gram-positive and gram-negative bacteria compared to clove oil (108). The bactericidal activity of the aqueous ethanolic extract of T. serpyllum for gastrointestinal disorders in a concentration range of 7.8 μg/mL – 500 μg/mL showed growth inhibition of Heliobacter pylori at 500 μg/mL in all strains (111). However, with such a high concentration needed, therapeutic benefits are unlikely. Different extraction methods (e.g., CES, UAE, and MWE), with impact on the antimicrobial activity of T. serpyllum were also investigated (112). T serpyllum exhibited the highest inhibition rate of 132.93% against Escherichia coli, and 78.40% against Candida albicans compared to other investigated medicinal plants (112).
The anti-fungal and anti-Candida activity of T. sepyllum has also been tested in several in-vitro models. The MIC value of T. serpyllum was 0.039 to 0.078% against tested bacteria and fungi, in addition to this, different combinations of essential oils and thymol with antibacterial and antifungal antibiotics were found to increase the efficacy of the antibiotics by 4–130 folds against bacterial and fungal pathogens (94). The mycelium was found to be less affected in the presence of T. serpyllum essential oil using Mycelial Growth Inhibition assay; at 0.25 mg/L, the MGI were 99%, while at the 0.5 mg/L of T. serpyllum essential oil, the MGI value drops to 22% (113). In contrast (114), reported that T. serpyllum did not show potent anticandidal or antifungal activity against tested strains. T. serpyllum essential oil samples were tested for their antifungal activity in human and animal skin, the MIC value of the fungi species was in the range of 0.5- > 10 mg/mL and the MFC were in the range of 1.25- > 10 mg/mL. T. serpyllum oil showed strong antifungal activity, especially against dermatophyte fungi (115). In a different study, T. serpyllum showed antifungal activity against oral isolates of Candida albicans and Candida glabara with a MIC value of 500–1,000 mg/L (116) (for more details, see Supplementary Table S2).
3.7.1.2 Anti-inflammatory activity
The anti-inflammatory activity of aqueous, ethanolic and methanolic extracts of T. serpyllum were tested in a number of assays, assessing the enzymes linked to inflammation, such as hyaluronidase, lipoxygenase (for inflammatory skin diseases) and src tyrosine kinase inhibitions (117, 118). At a concentration 150 μg/mL, the aqueous extract of T. serpyllum showed 71.7 ± 4.9% inhibition of the hyaluronidase activity, and it was dose dependant, and the IC50 value was 118.1 ± 7.1 μg/mL (118). In addition, the methanolic extract of T. serpyllum has been shown to inhibit the Src tyrosine kinase activity (for more details, see Supplementary Table S2).
3.7.1.3 Other pharmacological activities
The aqueous and methanolic extract of T. serpyllum were tested for a number of different pharmacological activities, e.g., chemopreventive activities and as an adjunct therapy for the cancer (119–121). Aqueous tea infusions and essential oils has shown to ameliorate the oxidation susceptibility of low-density lipoproteins (LDL) in a dose-dependent manner as found in a copper-induced LDL oxidation in-vitro model (122), antithrombin activity (123), antidiabetic/alpha-glucosidase inhibition activity (124, 125), liver and hepatoprotective activity (126) and anticholinesterase activity (127). The ethanolic and infusion extract of T. serpyllum were also looked at for its skin protective (photoprotective) activities, and it was the extract exhibited high values of Sun Protective Factors (SPF) with 38.34 ± 2.29 and 38.82 ± 2.23 for ethanol and infusion extract, respectively. These results suggest a potential use of T. serpyllum as a source of bioactive compounds with skin-protective properties (117, 128) (for more details, see Supplementary Table S2).
3.7.2 Pre-clinical (in-vivo) studies
3.7.2.1 Cardiovascular disease and metabolic syndrome
Several preclinical studies have been published on cardiovascular diseases, including antidiabetic (129–131), antihyperlipidemic and liver enzyme protective activities (132–134) of the aqueous extract of T. serpyllum. Ether and aqueous extract were found to reduce the blood glucose in diabetic rabbits (500 mg/kg b.w. with glibenclamide and acarbose as control), with aqueous extract inhibiting the rise in glucose level in the oral tolerance test (129). The extract showed a synergistic effect with different insulin levels; the HbA1c level was reduced, whereas the hemoglobin level was increased in the 3 months study (129).
Another study by the same research group in the same setting treated diabetic rabbits with a single high dose of 500 mg/kg of the aqueous extract. Blood samples were taken on day 0 and day 30. The extract has been shown to reduce the level of serum cholesterol, triglyceride, LDL, VLDL, alkaline phosphatase and transaminases without affecting the HDL level. The total cholesterol/HDL- ratio was significantly reduced as compared to diabetic control (132). These findings are unlikely to be of therapeutic relevance. This is due to the high dosage tested in this study, for examples, if we compare rabbit dose in mg/kg to human dose in mg/kg. With a rabbit to human conversion factor of 500/3.1, the human equivalent dose would be 161 mg/kg x 70 kg (human body weight) which implies a single dose of 11.3 g, making the study Alamgeer et al. (132) simply implausible (135).
A diabetes model of BALB/c mice fed with a high-fat diet and two streptozotocin (i.p.) injections was employed, and the mice were administered daily with an aqueous extract of T. serpyllum (500 and 800 mg/kg/d) for 4 weeks. This treatment was found to be significantly effective in controlling hyperglycemia and improving glucose and insulin tolerance. Within isolated liver tissue, upregulated mRNA levels of the AMPK, IRS1, and GLUT2 gene expression were elucidated. In addition, the cellular morphology of the liver, kidney, and pancreas was restored as revealed by histopathological examination (136). T. serpyllum mediated nanoparticles (10 mg/kg) have also shown strong antidiabetic activity on streptozocin-Induced diabetic BALB/c mice models, where it increase the AMPK and IRSI expressions, hence the increase update of glucose in cells (131).
The aqueous extract has also shown membrane-stabilizing properties in Wistar rat models (134). The mixture of commercial lactobacteria and Lactobacillus helveticus with water-soluble extract of T. serpyllum on a sterile milk basis has also appeared to have protective activity against toxicity and inflammation to the liver (133). The phytobacterial agent (150 mg/kg) seems to improve the microbiological indicators of the intestinal flora and the morphological parameters of the liver of white rats with intestinal dysbacteriosis (induced by the carbon tetrachloride and ampicillin trihydrate) (133).
The aqueous extract was also shown to have antihypertensive activity and decrease vascular resistance in hypertensive and normotensive rats (100 mg/kg b.w. as i.v. bolus in 0.2 saline) (130). This inverse correlation between vascular resistance and plasma heme oxygenease-1 was attributed to endogenous vasodilator carbon monoxide generated by heme oxidation could account for the normalization of blood pressure (130). The antihypertensive effect of the aqueous extract of T. serpyllum was elucidated with an injection of 100 mg/kg b.w. as i.v. bolus in 0.2 mL saline — induced a decrease of systolic and diastolic blood pressure and total peripheral resistance in spontaneously hypertensive rats (SHR) without effects on these parameters in normotensive Wistar rats. The results suggest that the aqueous extract may protect against hypertension in the experimental model of essential hypertension, while the cardiac index remained unchanged at the treatment in all experimental rats (137) (for more details, see Supplementary Table S3).
3.7.2.2 Anti-inflammatory activity
The extract of T. serpyllum extract was tested in a few in-vivo models (138–141). The aqueous extract showed intestinal anti-inflammatory effects in both experimental models of colitis (mimicking inflammatory bowel disease, IBD), as shown histologically as it facilitated tissue recovery of damaged colon and biochemically, as appeared by the improvement of the different inflammatory biomarkers, including myeloperoxidase activity, glutathione content, and leukotriene B4 levels as well as the expression of the inducible proteins iNO2, and COX-2 (138). Trinitrobenzenesulfonic acid models of rat colitis and dextran sodium sulfate model of mouse colitis, where two groups were given the extract at the doses of 100 or 250 mg/kg, and one group was treated with sulphasalazine at the dose of 50 mg/kg. The beneficial effect of T. serpyllum was associated with the reduction in the expression of different cytokines, e.g., TNFα, IL-1B, IFNy, IL-16, IL-17, the chemokine MCP-1 and the adhesion molecule ICAM-1. Thus ameliorating the altered immune response associated with the colonic inflammation (138).
The Codelac broncho syrup appears to have anti-inflammatory activity in the acute carrageenan inflammation of the paws in rats (139). The intragastric application of Codelac broncho syrup with T. serpyllum (0.17 mL/4 times a day), in comparison with fenspiride appeared to reduce paw volume increment compared to that of the control group starting with 4 h after the initiation of oedema by 42.4% (139).
The anti-inflammatory activity and gut dysbiosis of standardized extract of T. serpyllum on 70% native extract (DER native 4–8:1) and 30% dextrin were tested in a high-fat diet-induced obesity mice model (150 mg/kg) (142). The study showed that mice that consumed a high-fat diet exhibited thiobarbituric acid reactive substance (TBARS) values higher than standard diet groups; hence, administration of the extract to the high-fat diet-fed mice reduced TBARS values. Therefore, the daily consumption of the extract to high-fat diet-fed mice reduces the weight gain from day 6 onwards at all doses tested, considering the food intake was similar in all high diet-fed mice groups throughout the experimental period (142). The same group of researchers (143) elucidated anti-inflammatory and visceral analgesic benefits with the same extract mentioned above in a rat model of irritable bowel syndrome (IBS) (143) (for more details, see Supplementary Table S3).
3.7.2.3 Other pharmacological activities
Two earlier studies looked at the aqueous and ethanolic extracts of T. serpyllum for their antihormonal activity in male Wistar rat models (144, 145). It was found that the antithyrotropic and antithyroidal activity of a variety of plant extracts, including of T. serpyllum was accompanied by an additional prolactin diminution as well as the activity of different plant extracts depended on the extraction procedure, e.g., the extraction of powdered leaves with boiling water or ethanol yielded freeze-dried extracts without thyroid hormone-lowering capacity. The chemical oxidation of a hot-water (100°C) extract by KMn04 served to reintroduce the antihormonal activity (145). However, further studies are needed to define the active components of the extracts utilized in these studies and the mechanism of action for this effect (for more details, see Supplementary Table S3).
3.7.3 Clinical studies
3.7.3.1 Gut, digestive, and liver disorders
A recent human pilot study investigated the effects of an aqueous T. serpyllum herbal extract on gut health. In a Randomized Controlled Clinical Trial with 40 overweight subjects (N = 2×20) affected by functional gastrointestinal disorders (FGIDs), referred to as gut-brain interaction disorders, took 600 mg of aqueous T. serpyllum herbal extract before breakfast for eight weeks (146). The results of the study indicate that wild thyme has the potential to improve gastrointestinal symptoms and increase stool frequency. This also resulted in an improved quality of life. The stool microbiome of the study group was characterized by a high Firmicutes to Bacteroidetes ratio, which could be positively influenced by the intake of aqueous T. serpyllum herbal extract (146).
3.8 Safety
3.8.1 Toxicology and interactions
Thymus serpyllum and established preparations derived from the aerial parts are safe for use in foods, supplements, and herbal medicines when quality control is assured. No safety concerns have been identified in the literature reviewed, and extracts are generally recognized as safe and, as such, are GRAS-listed by the FDA (147). There are no known restrictions on the duration of use or contraindications for oral administration. No special warnings or precautions for use are required, and no drug interactions have been reported (32). No adverse and/or undesirable effects have been reported except for one potential report of acute kidney injury in a female over 75 years old in 2011, which is available on the VigiAccess-WHO website, and no cases of overdose have been reported. As a valuable culinary herb and spice, many food recipes rely on the addition of T. serpyllum to various dishes, soups, salads, marinades and sauces and define a framework for safe use. Based on general knowledge of the hazards of undiluted essential oils, wild thyme may cause irritation to the skin and mucous membranes (1).
As with other botanicals containing essential oils, caution should be exercised with enriched or pure essential oils (for detailed information on the antimicrobial effects of the essential oils, see Supplementary Table S2). Effects on microorganisms are also shown in the pharmacological activity part. Fumigant activity against food crop pests (148) and houseflies (49) is well established. In vitro, the cytotoxicity of extracts (e.g., containing rosmarinic and lithospermic acid) in cancer cell lines (149), particularly in human breast cancer (119), and human leukemia cells (120) has been investigated. Different cytotoxic modes of action of polyphenols in extracts and pure phenols (thymol, carvacrol) on different cancer cell lines are known; normal and healthy cells seem to be not negatively affected less or not negatively impacted (3). Extracts exert antigenotoxicity and genoprotective effects, e.g., in human fibroblasts (150).
In general, teas and tea-analogs preparations and related dry extracts are very safe based on their historical use, e.g., the daily intake of T. serpyllum is reported to be up to 12 g of herbal tea acc. to BHP 1983/Potter 2002. Even extracts prepared with pure ethanol and tested for toxicity according to the OECD 423 guideline do not show any acute toxicity in mice at doses up to 2000 mg/kg (151). On the other hand, a methanolic extract exerts significant activity in brine shrimp lethality assay and antitumor assay, which is interpreted as a valuable anticancer principle (152). The essential oil of T. serpyllum reveals strong anticancer properties, as reported by Nikolic et al. (93).
The essential oil’s composition of Thymus species, including T. vulgaris/zygis and T. serpyllum varies between different chemotypes, although they are considered similar under safety aspects. Mixtures of the constituents, e. g. thymol plus carvacrol appear to behave differently and be less toxic than Thymol alone. Many essential oils of Thyme spp. are GRAS, i.e., not mutagenic, not embryotoxic in mice and show no skin irritation up to 2% in fragrance-sensitive volunteers. These results suggest that thyme oil (Thymol/Carvacrol rich) is less toxic than would be expected of thymol and carvacrol alone and from the data on their individual toxicity data. The Commission E Monographs thyme is considered with two approved (positive) monographs: Thymi herba (Thymus vulgaris) and Serpylli herba (T. serpyllum) (31, 68). There is no data available with regard to interaction risks since there is only a single intervention study.
3.9 Scientific applications and translational research
In light of the burgeoning exploration of botanical concoctions and their influence on gastrointestinal wellness and microbiome composition, the compatibility between probiotics and plant extracts has emerged as a pivotal topic of inquiry. Pertinent to this discussion is the case of aqueous wild thyme extracts. The seminal work of Vitas et al. (153) offers compelling evidence in this regard. Their study, focusing on the kombucha fermentation of thyme tea, observed a notable increase in titratable acidity. This phenomenon is indicative of the metabolic vigor of the probiotic strains present in kombucha, thereby underscoring the potential synergistic relationship between such herbal extracts and probiotics.
4 Conclusion
Wild thyme (T. serpyllum L.), a herb native to Eurasia and North Africa, now cultivated globally, is renowned for its essential oil with thymol or carvacrol as key components. While the essential oil content is less than 1% in dry herbs, the non-volatile phytochemicals, primarily rosmarinic acid, phenolic acids, flavonoids, di- and triterpenoids, significantly contribute to its wider commercial potential, including its nutritional value and preventive health benefits. These compounds have been shown to be effective in preventing, managing and treating several health conditions, making wild thyme a valuable functional food and a component in cosmetic and skin care products.
The chemical composition of the plant, influenced by geographical and climatic factors, underpins its health benefits and traditional use in culinary, nutritional, medicinal, and aromatic applications. Traditionally used in local and traditional medicine, particularly for respiratory and gastrointestinal conditions, wild thyme has been the subject of extensive biochemical research and scientific studies, including in vitro, in vivo, and some clinical trials. These studies have confirmed specific anti-inflammatory, hepato-protective, and cardiovascular benefits, including its role in managing and treating metabolic syndrome. Of particular significance is a recent human clinical trial that demonstrated wild thyme’s effectiveness in improving gastrointestinal symptoms and overall gut health, a finding that builds upon its previously established preventive and therapeutic health benefits in rodent models for inflammatory bowel diseases and irritable bowel syndromes. With an excellent safety and tolerability profile, wild thyme presents a promising avenue for various therapeutic, preventive and commercial applications.
Despite encouraging evidence, further rigorous controlled intervention studies with well-characterized preparations of wild thyme (7) as well as well-designed experimental protocols and models are necessary to fully understand and harness its therapeutic potential as well as preventive health benefits.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
BJ: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. IP: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. BF: Writing – original draft, Writing – review & editing. CS: Methodology, Writing – original draft, Writing – review & editing. AB: Writing – original draft, Writing – review & editing. RS: Writing – original draft, Writing – review & editing. RR-E: Writing – original draft, Writing – review & editing. MH: Conceptualization, Methodology, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article: IP and BJ received financial support for the analysis of the data and the development of the manuscript.
In memoriam
We dedicate this paper to Prof. Peter Houghton, formerly Kings College London and a vicar of the Church of England, who passed away on 25.04.24 in Hereford, UK. He will be remembered as a wonderful colleague and great pharmacognosist/ethnopharmacologist.
Conflict of interest
IP and BJ received some financial support from Finzelberg GmbH & Co. KG, Andernach, Germany, for the analysis of the data and the development of the manuscript. RS, CS, AB, BF, and RR-E are employed by Finzelberg GmbH & Co. KG. Finzelberg is a company producing and distributing botanical extracts and their input into this project relates to specific aspects/questions like the assessment of the IP status, production techniques and product analysis. The team is working in research and development of new products.
The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2024.1380962/full#supplementary-material
References
2. Jarić, S, Mitrović, M, and Pavlović, P. Review of ethnobotanical, phytochemical, and pharmacological study of Thymus serpyllum L. Evid Based Complement Alternat Med. (2015) 2015:101978. doi: 10.1155/2015/101978
3. Jovanović, AA, Balanč, B, Petrović, P, Pravilović, R, and Djordjević, V. Pharmacological potential of Thymus serpyllum L.(wild thyme) extracts and essential oil: a review. J Eng Proces Manag. (2021) 13:32–41. doi: 10.7251/JEPM2102032J
4. Li, J, Chen, W, Liu, H, Liu, H, Xiang, S, You, F, et al. Pharmacologic effects approach of essential oils and their components on respiratory diseases. J Ethnopharmacol. (2023) 304:115962. doi: 10.1016/j.jep.2022.115962
5. Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71
6. Heinrich, M, Appendino, G, Efferth, T, Fürst, R, Izzo, AA, Kayser, O, et al. Best practice in research–overcoming common challenges in phytopharmacological research. J Ethnopharmacol. (2020) 246:112230. doi: 10.1016/j.jep.2019.112230
7. Heinrich, M, Jalil, B, Abdel-Tawab, M, Echeverria, J, Kulić, Ž, McGaw, LJ, et al. Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research—the ConPhyMP—guidelines. Front Pharmacol. (2022) 13:953205. doi: 10.3389/fphar.2022.953205
9. Pigott, C . Species delimitation and racial divergence in British Thymus. New Phytol. (1954) 53:470–95. doi: 10.1111/j.1469-8137.1954.tb05255.x
10. Köhler, F. E. (1887). Kohler's Medicinal Plants (Köhler's Medizinal-Pflanzen in naturgetreuen Abbildungen mit kurz erläuterndem Texte: Atlas zur Pharmacopoea germanica).
11. Alamy . (n.d.) Alamy. Available at: https://www.alamy.com/?utm_source=google&utm_medium=cpc&utm_campaign=&utm_content=&gad_source=1&gclid=CjwKCAiA_OetBhAtEiwAPTeQZyOQT4S5UVri26P2F-IXeRIE2t99p2JmBUzzYDTOY2jtxl-Du7qVgBoCHaMQAvD_BwE (Accessed August 15, 2022).
12. 123RF . (n.d.) 123RF. Available at: https://www.123rf.com/ (Accessed August 15, 2022).
13. Hassler, M. (1994–2024). World Plants. Synonymic Checklist and Distribution of the World Flora. Available at: https://www.worldplants.de/world-plants-complete-list/complete-plant-list (Accessed January 10, 2024).
14. Harper, D. (2001–2023). “thyme”, in Online Etymology Dictionary. Available at: https://www.etymonline.com/word/thyme (Accessed January 10, 2024).
15. Liddell, HG, and Scott, R. An intermediate Greek-English lexicon: Founded upon the seventh edition of Liddell and Scott's Greek-English lexicon. Manhattan, NY: Harper & Brothers (1896).
17. Lewis, C, and Short, C. A Latin dictionary (Impression of 1958). Oxford: Clarendon Press (1879).
18. Gernot-Katzers . (2003). Thyme (Thymus serpyllum L.). Available at: http://gernot-katzers-spice-pages.com/germ/Thym_vul.html) (Accessed January 10, 2024).
19. GBIF Secretariat . (2023). Thymus serpyllum L. in GBIF backbone taxonomy. Available at: https://doi.org/10.15468/39omei (Accessed December 13, 2023).
20. Plants for the Future . (2010–2024). Thymus serpyllum L. [Online]. Available at: https://pfaf.org/user/plant.aspx?latinname=Thymus+serpyllum (Accessed January 10, 2024).
21. An Eco-Sustainable World . (2022). Thymus serpyllum. Available at: https://antropocene.it/en/2022/10/26/thymus-serpyllum-en/ (Accessed January 10, 2024).
22. Chauhan, NK, Singh, S, Lohani, H, and Haider, SZ. Effect of different harvesting time on growth, yield and quality of thyme (Thymus serpyllum L.) under the agro-climatic conditions of Doon valley, Uttarakhand. J Chem Pharm Res. (2011) 3:982–6.
23. Heeger, EF . Handbuch des Arznei-und Gewürzpflanzenbaues: Drogengewinnung. Berlin: Deutscher Bauernverlag (1956).
24. CBI EU . (2020). The European market potential for dried thyme. Available at: https://www.cbi.eu/market-information/spices-herbs/thyme/market-potential (Accessed January 10, 2024).
25. Van Wyk, B-E . Culinary herbs and spices of the world. Chicago: University of Chicago Press (2014).
26. Siminiuc, R, and Turcano, D. Study of edible spontaneous herbs in the Republic of Moldova for ensuring a sustainable food system. Food Nutr Sci. (2021) 12:703–18. doi: 10.4236/fns.2021.127053
27. Blaschek, W, Ebel, S, Hackenthal, E, Holzgrabe, U, Keller, K, Reichling, J, et al. Hagers Enzyklopädie der Arzneistoffe und Drogen. Stuttgart: Wiss Verlag-Ges (2016).
28. British Herbal Compendium . Monograph wild thyme (Serpylli herba). Bournemouth, UK: British Herbal Medicine Association (2006).
29. Brinckmann, JA, Lindenmaier, MP, and Wichtl, M. Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis. Boca Raton, FL: CRC Press (2004).
30. Benedum, J, Loew, D, and Schilcher, H. Arzneipflanzen in der traditionellen Medizin. Bonn: Kooperation Phytopharmaka (2006).
31. Blumenthal, M . The complete German commission E monographs. Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council (1999).
32. ESCOP . Serpylli herba wild thyme. Devon: The European Scientifc Cooperative on Phytotherapy (2014).
33. Farmacopoea Official Española . Monograph Serpol – Serpyllum. Medrid, Spain: Gregorio Estrada (1884).
34. Deutsches Arzneibuch . Monograph Herba Serpylli (Quendel), species aromaticae. Stuttgart, Germany: Deutscher Apotheker-Verlag (1926).
35. Farmacopeia Portoguesa, IV . Monograph Serpilho (Serpyllum, Serpão). Portogal Imprensa Nacional de Lisboa: Lisboa (1946).
36. Pharmacopoea Hungarica VI . Magyar Gyógyszerkönyv (Pharmacopaea Hungarica) VI, III In: Monograph Serpylli herba (Mezei Kakukkfú). Budapest, Czech Repulic: Medicina Könyv Kiadó (1967–1971)
37. British Herbal Pharmacopoeia . Monograph Thymus serpyllum. Bournemouth, UK: British Herbal Medicine Association (1983).
38. Pharmacopée française janvier . Liste A des plantes médicinales utilises traditionellement. Paris: France (2017).
39. Pharmacopoeia European . Monograph Quendelkraut –Serpylli herba. Stuttgart, Germany: Deutscher Apotheker Verlag (2022).
40. Zarzuelo, A, and Crespo, E. The medicinal and non-medicinal uses of thyme. In: Stahl-Biskup E and Sáez F (Ed.). Thyme: the genus Thymus. London, UK: CRC Press (2002). p. 277–306.
41. Brasseur, T . Etudes botaniques, phytochimiques et pharmacologiques consacrees au Thym. J Pharm Belgium. (1983) 38:261–72.
42. González, A . Secretos y virtudes de las plantas medicinales. Madrid: Selecciones del Reader’s Digest (1980).
43. Arctander, S . Perfum and flavor materials of natural origin. Morrisville, NJ: Lulu Press (1960).
44. Valnet, J . Aromathérapie. Traitement des maladies par les essences des plantes. Maloine: Paris, France (1964).
45. Bánóczy, J, Gombik, A, Szöke, J, and Nasz, I. Effect of an antibacterial varnish and amine-fluoride/stannous fluoride (AmF/SnF2) toothpaste on Streptococcus mutans counts in saliva and dental plaque of children. J Clin Dent. (1995) 6:131–4.
46. Marsh, P . Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res. (1992) 71:1431–8. doi: 10.1177/00220345920710071501
47. European Commission . (n.d.) CosIng – Cosmetics Ingredients. Available at: https://ec.europa.eu/growth/tools-databases/cosing/ (Accessed January 10, 2024).
48. Galovičová, L, Borotová, P, Valková, V, Vukovic, NL, Vukic, M, Terentjeva, M, et al. Thymus serpyllum essential oil and its biological activity as a modern food preserver. Plan Theory. (2021) 10:1416. doi: 10.3390/plants10071416
49. Xie, Y, Jin, H, Yang, X, Gu, Q, and Zhang, D. Toxicity of the essential oil from Thymus serpyllum and thymol to larvae and pupae of the housefly Musca domestica L.(Diptera: Muscidae). Environ Sci Pollut Res. (2020) 27:35330–40. doi: 10.1007/s11356-020-09633-z
50. Sivaram, S, Somanathan, H, Kumaresan, SM, and Muthuraman, MS. The beneficial role of plant based thymol in food packaging application: a comprehensive review. Appl Food Res. (2022) 2:100214. doi: 10.1016/j.afres.2022.100214
51. Nieto, G . A review on applications and uses of thymus in the food industry. Plan Theory. (2020) 9:961. doi: 10.3390/plants9080961
52. European Medicines Agency . (2022). European Union monographs and list entries. Available at: https://www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products/european-union-monographs-and-list-entries (Accessed August 15, 2022).
54. Royal Decree . (2021). Arrêté royal relatif à la fabrication et au commerce de denrées alimentaires composées ou contenant des plantes ou préparations de plantes (Manufacturing and trade foodstuffs composed of or containing plants or herbal preparations. Available at: https://www.health.belgium.be/fr/version-consolidee-arrete-royal-du-29-aout-1997 (Accessed August 15, 2022).
55. Pravilnik (2011). NN 46/2011 – Pravilnik o dodacima prehrani (Regulation on dietary supplements). Available at: https://narodne-novine.nn.hr/clanci/sluzbeni/2011_04_46_1066.html (Accessed August 15, 2022).
56. Decree . (2014). Plantes dont l’emploi est autorisé dans les complements alimentaires (Authorised plants in food supplements). Available at: https://www.legifrance.gouv.fr/loda/id/JORFTEXT000029254516 (Accessed August 15, 2022).
57. Bundesamts für Verbraucherschutz und Lebensmittelsicherheit . (2020). List of Substances of the Competent Federal Government and Federal Stat Authorities – Category “Plants and plants part.
58. Ministerial Decree . (2018). Allegato 1 on sulla disciplina dell'impiego negli integratori alimentari di Sostanze e preparati vegetali (Annex 1 on the regulation of the use of plant substances and preparations in food supplements).
59. European Food Safety Authority . (2022). "General function" health claims under Article 13. Available at: https://www.efsa.europa.eu/en/topics/topic/general-function-health-claims-under-article-13 (Accessed August 15, 2022).
60. European Food Safety Authority . (2010). Scientific Opinion on the substantiation of health claims related to various food(s)/food constituent(s) claiming an increase in renal water elimination, “kidneys health”, “urinary health”, “bladder health”, “health of lower urinary tract”, “blood health”, “elimination”, “urinary system benefits” and/or “supports/promotes the excretory function of the kidney”, and treatment/prevention of renal gravel/kidney stones and urinary tract. Available at: https://www.efsa.europa.eu/en/efsajournal/pub/1742 (Accessed August 15, 2022).
61. GB/T 12729.1 . (2020). National Standard of the People’s Republic of China. Spices and Condiments. Available at: https://www.chinesestandard.net/PDF/English.aspx/GBT12729.1-2008 (Accessed August 15, 2022).
62. GB/T 31326 . (2014). National Standard of the People’s Republic of China. Botanical Beverage. Available at: https://www.chinesestandard.net/PDF/English.aspx/GBT31326-2014 (Accessed August 15, 2022).
63. Food Code . (2020). Appendix 1: List of “raw materials that can be used in food” Available at: https://www.foodsafetykorea.go.kr/foodcode/01_03.jsp?idx=814 (Accessed August 15, 2022).
64. Non-Pharmaceutical List . (2021). Hokeniryo. Available at: https://www.hokeniryo.metro.tokyo.lg.jp/annai.html (Accessed January 15, 2022).
65. Food Safety and Standards Authority of India . (2016). Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations. List of plant or botanical ingredients. Available at: https://www.fssai.gov.in/upload/uploadfiles/files/Compendium_Nutra_29_09_2021.pdf (Accessed August 15, 2022).
66. Zimmermann, M, Johnson, HE, McGuffin, M, and Applequist, W. Herbs of Commerce, 3rd Ed. Silver Spring, MD: American Herbal Products Association (2023).
67. Food and Drug Administration . (n.d.) Submitted 75-Day Premarket Notifications for New Dietary Ingredients (NDIN). Available at: https://www.fda.gov/food/new-dietary-ingredient-ndi-notification-process/submitted-75-day-premarket-notifications-new-dietary-ingredients (Accessed August 15, 2022).
68. Code of Federal Regulation . (n.d.) Part 182—substances generally recognized as safe. Available at: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-182#182.20 (Accessed August 15, 2022).
69. Shahar, B, Indira, A, Santosh, O, Dolma, N, and Chongtham, N. Nutritional composition, antioxidant activity and characterization of bioactive compounds from Thymus serpyllum L.: an underexploited wild aromatic plant. Measurement Food. (2023) 10:100092. doi: 10.1016/j.meafoo.2023.100092
70. Abu-Darwish, MS . Essential oils yield and heavy metals content of some aromatic medicinal plants grown in ash-shoubak region, south of Jordan. Adv Environ Biol. (2009) 3:296–301.
71. Figas, A, Tomaszewska-Sowa, M, Kobierski, M, Sawilska, AK, and Klimkowska, K. Hazard of contamination with heavy metals in Thymus serpyllum L. Herbs from Rural Areas. Agriculture. (2021) 11:375. doi: 10.3390/agriculture11040375
72. Vasil'eva, IE, Shabanova, EV, Tsagaan, B, and Bymbaa, K. Elemental profiles of wild Thymus L. Plants Growing in Different Soil and Climate Conditions. Appl Sci. (2022) 12:3904. doi: 10.3390/app12083904
73. Duke, JA . Handbook of phytochemical constituents of GRAS herbs and other economic plants. Boca Raton, FL: CRC Press. (1992).
74. Yang, R, Dong, Y, Gao, F, Li, J, Stevanovic, ZD, Li, H, et al. Comprehensive analysis of secondary metabolites of four medicinal thyme species used in folk medicine and their antioxidant activities in vitro. Molecules. (2023) 28:2582. doi: 10.3390/molecules28062582
75. Bączek, K, Pióro-Jabrucka, E, Kosakowska, O, and Węglarz, Z. Intraspecific variability of wild thyme (Thymus serpyllum L.) occurring in Poland. J Appl Res Med Aromatic Plants. (2019) 12:30–5. doi: 10.1016/j.jarmap.2018.11.001
76. Kryvtsova, M, Hrytsyna, M, Salamon, I, Skybitska, M, and Novykevuch, O. Chemotypes of species of the genus Thymus L. in Carpathians region of Ukraine—their essential oil qualitative and quantitative characteristics and antimicrobial activity. Horticulturae. (2022) 8:1218. doi: 10.3390/horticulturae8121218
77. Steflitsch, W, Wolz, D, Buchbauer, G, Stadelmann, I, and Heuberger, E. Aromatherapie in Wissenschaft und Praxis. Wiggensbach: Stadelmann Verlag (2021).
78. USDA . (1992–2016). Dr. Duke's phytochemical and ethnobotanical databases [online]. Available at: https://phytochem.nal.usda.gov/ (Accessed November 15, 2023).
79. Meier, M . (1992–2016). Einsatzmöglichkeiten der HPTLC-MS Kopplung bei der Untersuchung von Heilpflanzen. Diploma Thesis, University Graz, AT. (2011).
80. Iuliana, CC, Gabriela, HN, Szakal, R, Veronica, P, Sofia, PPG, Riviş, A, et al. Antioxidant activity of thyme extracts. Influence of the extraction solvent. J Horticult Forestry Biotechnol. (2014) 18:126–32.
81. Ivasenko, S, Zhumabekova, A, Ludwiczuk, A, Skalicka-Wozniak, K, Marchenko, A, Ishmuratova, M, et al. Antimicrobial activity and polyphenol profiles of hydroalcoholic extracts of thymus rasitatus klokov and thymus eremita klokov. Open Access Maced J Med Sci. (2021) 9:313–7. doi: 10.3889/oamjms.2021.6117
82. Litvinenko, V, and Zoz, I. Chemotaxonomic study of Thymus species in the Ukranie. Rast Resur. (1969) 5:481–95.
83. Semrau, R . Über die Flavone in der Familie der Labiaten. Munich: Ludwig-Maximilians Universität München (1958).
84. Van den Broucke, C, Lemli, J, and Lamy, J. Action spasmolytique des flavones de differentes especes de Thymus. Plantes Medicinal Phytotherapy. (1983) 16:310–7.
85. Washington, JS, and Saxena, VK. A new acylated apigenin 4′-O-β-D-glucoside from the stems of Thymus serpyllum L. J Institute Chem (India). (1983)
86. Kern, W, Roth, H, Schmid, W, List, PH, and Hörhammer, L. Hagers Handbuch der pharmazeutischen Praxis: für Apotheker Arzneimittelhersteller Ärzte und Medizinalbeamte. Ausgabe: Springer Verlag (1967).
87. Mrkonjic, Ž, Rakic, D, Takaci, A, Kaplan, M, Teslic, N, Zekovic, Z, et al. Polyphenols recovery from Thymus serpyllum industrial waste using microwave-assisted extraction–comparative RSM and ANN approach for process optimization. Food Secur. (2022, 2022) 11:1184. doi: 10.3390/foods11091184
88. Boros, B, Jakabova, S, Dornyei, A, Horvath, G, Pluhar, Z, Kilar, F, et al. Determination of polyphenolic compounds by liquid chromatography-mass spectrometry in Thymus species. J Chromatogr A. (2010) 1217:7972–80. doi: 10.1016/j.chroma.2010.07.042
89. Fecka, I, and Turek, S. Determination of polyphenolic compounds in commercial herbal drugs and spices from Lamiaceae: thyme, wild thyme and sweet marjoram by chromatographic techniques. Food Chem. (2008) 108:1039–53. doi: 10.1016/j.foodchem.2007.11.035
90. Ivasenko, S, Orazbayeva, P, Skalicka-Wozniak, K, Ludwiczuk, A, Marchenko, A, Ishmuratova, M, et al. Antimicrobial activity of ultrasonic extracts of two chemotypes of thymus serpyllum L. of Central Kazakhstan and their polyphenolic profiles. Open Access Maced J Med Sci. (2021) 9:61–7. doi: 10.3889/oamjms.2021.5520
91. Abu-Darwish, MS, Al-Ramamneh, E, Kyslychenko, VS, and Karpiuk, UV. The antimicrobial activity of essential oils and extracts of some medicinal plants grown in ash-shoubak region-south of Jordan. Pak J Pharm Sci. (2012) 25:239–46.
92. Gāliņa, D, Radenkovs, V, Kviesis, J, and Valdovska, A. Effect of essential oils supplemented with Caprylic acid and sodium chloride against Faecal ESBL-producing Escherichia coli isolated from pigs. Antibiotics. (2022) 11:461. doi: 10.3390/antibiotics11040461
93. Nikolic, M, Glamoclija, J, Ferreira, I, Calhelha, RC, Fernandes, A, Markovic, T, et al. Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L., Thymus algeriensis Boiss. And Reut and Thymus vulgaris L. essential oils. Ind Crop Prod. (2014) 52:183–90. doi: 10.1016/j.indcrop.2013.10.006
94. Salaria, D, Rolta, R, Patel, CN, Dev, K, Sourirajan, A, and Kumar, V. In vitro and in silico analysis of Thymus serpyllum essential oil as bioactivity enhancer of antibacterial and antifungal agents. J Biomol Struct Dyn. (2022) 40:10383–402. doi: 10.1080/07391102.2021.1943530
95. Shanaida, M, Hudz, N, Bialon, M, Kryvtsowa, M, Svydenko, L, Filipska, A, et al. Chromatographic profiles and antimicrobial activity of the essential oils obtained from some species and cultivars of the Mentheae tribe (Lamiaceae). Saudi J Biol Sci. (2021) 28:6145–52. doi: 10.1016/j.sjbs.2021.06.068
96. Shapoval, OG, Sheremetyeva, AS, Durnova, NA, Mukhamadiev, NK, Rabbimova, GT, Nazirbekov, MK, et al. Antibacterial activity of essential oils of creeping thyme (Thymus serpyllum L.) and Marshall thyme (Thymus marschallianus Willd). Dev Regist Med. (2023) 12:143–50. doi: 10.33380/2305-2066-2023-12-3-143-150
97. Štefanidesová, K, Škultéty, Ľ, Friedländerová, V, Šáner, A, and Špitalská, E. The effect of wild thyme and bergamot essential oils on the growth of rickettsia slovaca and Rickettsia conorii caspia in Vero cell line. Travel Med Infect Dis. (2018) 26:69–71. doi: 10.1016/j.tmaid.2018.10.009
98. Ouedrhiri, W, Mechchate, H, Moja, S, Baudino, S, Saleh, A, Al Kamaly, OM, et al. Optimized antibacterial effects in a designed mixture of essential oils of Myrtus communis, Artemisia herba-alba and Thymus serpyllum for Wide Range of Applications. Foods. (2022) 11:11. doi: 10.3390/foods11010132
99. Ouedrhiri, W, Mounyr, B, Harki, E, Moja, S, and Greche, H. Synergistic antimicrobial activity of two binary combinations of marjoram, lavender, and wild thyme essential oils. Int J Food Prop. (2017) 20:3149–58. doi: 10.1080/10942912.2017.1280504
100. Listorti, V, Battistini, R, Ercolini, C, Tramuta, C, Razzuoli, E, Vencia, W, et al. In vitro susceptibility of multidrug resistant strains of Salmonella to essential oils. Nat Products Commun. (2020) 15:1934578X1987890. doi: 10.1177/1934578X19878904
101. Juliano, C, Mattana, A, and Usai, M. Composition and in vitro antimicrobial activity of the essential oil of Thymus herba-barona Loisel growing wild in Sardinia. J Essent Oil Res. (2000) 12:516–22. doi: 10.1080/10412905.2000.9699578
102. Jovanka, L, Ivana, C, Goran, T, Sava, P, Slavica, S, Tamara, CG, et al. In vitro antibacterial activity of essential oils from plant family Lamiaceae. Romanian Biotechnol Lett. (2011) 16:6034–41.
103. Kavyashree, M, and Rajasekar, A. Antimicrobial activity of polyherbal extract: an in vitro study. Int J Dentistry Oral Sci. (2021) 8:5567–73. doi: 10.19070/2377-8075-21000930
104. Verma, RS, Padalia, RC, Saikia, D, Chauhan, A, Krishna, V, and Sundaresan, V. Chemical composition and antimicrobial activity of the essential oils isolated from the herbage and aqueous distillates of two Thymus species. J Essent Oil Bear Plants. (2016) 19:936–43. doi: 10.1080/0972060X.2014.935071
105. Aziz, S, Irshad, M, and Habib, R. Isolation of a new antibacterial polyphenol from Thymus serpyllum. Chem Nat Compd. (2014) 49:1023–7. doi: 10.1007/s10600-014-0814-2
106. Nedorostova, L, Kloucek, P, Urbanova, K, Kokoska, L, Smid, J, Urban, J, et al. Antibacterial effect of essential oil vapours against different strains of Staphylococcus aureus, including MRSA. Flavour Fragr J. (2011) 26:403–7. doi: 10.1002/ffj.2068
107. Abramovič, H, Abram, V, Čuk, A, Čeh, B, Smole Možina, S, Vidmar, M, et al. Antioxidative and antibacterial properties of organically grown thyme (Thymus sp.) and basil (Ocimumbasilicum L.). Turk J Agric For. (2018) 42:185–94. doi: 10.3906/tar-1711-82
108. Bayoub, K, Baibai, T, Mountassif, D, Retmane, A, and Soukri, A. Antibacterial activities of the crude ethanol extracts of medicinal plants against listeria monocytogenes and some other pathogenic strains. Afr J Biotechnol. (2010) 9:4251–8.
109. Okragla, E, Chraniuk, M, and Wolska, L. MICROTOX test as a tool to assess antimicrobial properties of herbal infusions used in urinary tract infections. Acta Pol Pharm. (2017) 74:895–901.
110. Tamert, A, Latreche, A, and Aouad, L. Phytochemical screening and antimicrobial activity of extracts of Thymus serpyllum and Thymus vulgaris from the mount of Tessala (Western Algeria). Phytothérapie. (2017) 15:384–94. doi: 10.1007/s10298-017-1132-1
111. Zaidi, SFH, Yamada, K, Kadowaki, M, Usmanghani, K, and Sugiyama, T. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J Ethnopharmacol. (2009) 121:286–91. doi: 10.1016/j.jep.2008.11.001
112. Horablaga, NM, Cozma, A, Alexa, E, Obistioiu, D, Cocan, I, Poiana, M-A, et al. Influence of sample preparation/extraction method on the phytochemical profile and antimicrobial activities of 12 commonly consumed medicinal plants in Romania. Appl Sci. (2023) 13:2530. doi: 10.3390/app13042530
113. Rus, C, Sumalan, RM, Alexa, E, Copolovici, DM, Pop, G, and Botau, D. Study on chemical composition and antifungal activity of essential oils obtained from representative species belonging to the Lamiaceae family. Plant Soil Enviroment. (2015) 61:297–302. doi: 10.17221/177/2015-PSE
114. Jamali, CA, El Bouzidi, L, Bekkouche, K, Lahcen, H, Markouk, M, Wohlmuth, H, et al. Chemical composition and antioxidant and Anticandidal activities of essential oils from different wild Moroccan Thymus species. Chem Biodivers. (2012) 9:1188–97. doi: 10.1002/cbdv.201200041
115. Michalczyk, A, and Ostrowska, P. Essential oils and their components in combating fungal pathogens of animal and human skin. J Med Mycol. (2021) 31:101118. doi: 10.1016/j.mycmed.2021.101118
116. Baj, T, Biernasiuk, A, Wrobel, R, and Malm, A. Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of Candida albicans and Candida glabrata. Open Chem. (2020) 18:108–18. doi: 10.1515/chem-2020-0011
117. Kindl, M, Bucar, F, Jelic, D, Brajsa, K, Blazekovic, B, and Vladimir-Knezevic, S. Comparative study of polyphenolic composition and anti-inflammatory activity of Thymus species. Eur Food Res Technol. (2019) 245:1951–62. doi: 10.1007/s00217-019-03297-x
118. Mainka, M, Czerwińska, ME, Osińska, E, Ziaja, M, and Bazylko, A. Screening of antioxidative properties and inhibition of inflammation-linked enzymes by aqueous and ethanolic extracts of plants traditionally used in wound healing in Poland. Antioxidants. (2021) 10:698. doi: 10.3390/antiox10050698
119. Berdowska, I, Zielinski, B, Fecka, I, Kulbacka, J, Saczko, J, and Gamian, A. Cytotoxic impact of phenolics from Lamiaceae species on human breast cancer cells. Food Chem. (2013) 141:1313–21. doi: 10.1016/j.foodchem.2013.03.090
120. Berdowska, I, Zielinski, B, Matusiewicz, M, and Fecka, I. Modulatory impact of Lamiaceae metabolites on apoptosis of human leukemia cells. Front Pharmacol. (2022) 13:867709. doi: 10.3389/fphar.2022.867709
121. Bozkurt, E, Atmaca, H, Kisim, A, Uzunoglu, S, Uslu, R, and Karaca, B. Effects of Thymus serpyllum extract on cell proliferation, apoptosis and epigenetic events in human breast Cancer cells. Nutr Cancer. (2012) 64:1245–50. doi: 10.1080/01635581.2012.719658
122. Kulisic, T, Krisko, A, Dragovic-Uzelac, V, Milos, M, and Pifat, G. The effects of essential oils and aqueous tea infusions of oregano (Origanum vulgare L. spp. hirtum), thyme (Thymus vulgaris L.) and wild thyme (Thymus serpyllum L.) on the copper-induced oxidation of human low-density lipoproteins. Int J Food Sci Nutr. (2007) 58:87–93. doi: 10.1080/09637480601108307
123. Goun, EA, Petrichenko, VM, Solodnikov, SU, Suhinina, TV, Kline, MA, Cunningham, G, et al. Anticancer and antithrombin activity of Russian plants. J Ethnopharmacol. (2002) 81:337–42. doi: 10.1016/S0378-8741(02)00116-2
124. Gholamhoseinian, A, Fallah, H, Sharifi-Far, F, and Mirtajaddini, M. The inhibitory effect of some iranian plants extracts on the alpha glucosidase. Iran J Basic Med Sci. (2008) 11:1–9. doi: 10.22038/IJBMS.2008.5190
125. Pavlović, MO, Lunić, T, Graovac, S, Mandić, M, Repac, J, Gašić, U, et al. Extracts of selected Lamiaceae species as promising antidiabetics: chemical profiling, in vitro and in silico approach combined with dynamical modeling. Ind Crop Prod. (2022) 186:115200. doi: 10.1016/j.indcrop.2022.115200
126. Aralbaeva, AN, Mamataeva, AT, Zhaparkulova, NI, Utegalieva, RS, Khanin, M, Danilenko, M, et al. A composition of medicinal plants with an enhanced ability to suppress microsomal lipid peroxidation and a protective activity against carbon tetrachloride-induced hepatotoxicity. Biomed Pharmacother. (2017) 96:1283–91. doi: 10.1016/j.biopha.2017.11.085
127. Kindl, M, Blazekovic, B, Bucar, F, and Vladimir-Knezevic, S. Antioxidant and Anticholinesterase Potential of Six Thymus Species. Evid Based Complement Alternat Med. (2015) 2015:1–10. doi: 10.1155/2015/403950
128. Madouni, N, Meddah, B, Aicha, TT, Bensouici, C, Cakmak, YS, Piras, A, et al. Chemical profile, antioxidant and photoprotective activities of essential oil and crude extracts of Algerian Thymus serpyllum. Nova Biotechnologica et Chimica. (2021) 20:916. doi: 10.36547/nbc.916
129. Alamgeer,, and Mushtaq, MN. Effect of aqueous extract of Thymus serpyllum on lipid profile and some liver enzymes in alloxan-induced diabetic rabbit. Bangladesh J Pharmacol. (2017) 12:58–62. doi: 10.3329/bjp.v12i1.29606
130. Mihailovic-Stanojevic, N, Miloradović, Z, Ivanov, M, Bugarski, B, Jovović, D, Karanović, D, et al. Upregulation of Heme Oxygenase-1 in response to wild thyme treatment protects against hypertension and oxidative stress. Oxidative Med Cell Longev. (2016) 2016:1–11. doi: 10.1155/2016/1458793
131. Wahab, M, Bhatti, A, and John, P. Evaluation of antidiabetic activity of biogenic silver nanoparticles using Thymus serpyllum on Streptozotocin-induced diabetic BALB/c mice. Polymers. (2022) 14:3138. doi: 10.3390/polym14153138
132. Alamgeer, M, Mushtaq, MN, Bashir, S, Ullah, I, Karim, S, Rashid, M, et al. Comparative hypoglycemic activity of different fractions of Thymus serpyllum L. in alloxan induced diabetic rabbits. Pak J Pharm Sci. (2016) 29:1483–8.
133. Tarmakova, SS, Sanzhieva, SY, and Nikolaeva, ES. Impact of phytobacterial agent on the toxic damage to the liver and ileum of white rats. Arch Razi Institute. (2019) 74:287–94. doi: 10.22092/ari.2019.125886.1324
134. Ydyrys, A, Zhaparkulova, N, Aralbaeva, A, Mamataeva, A, Seilkhan, A, Syraiyl, S, et al. Systematic analysis of combined antioxidant and membrane-stabilizing properties of several Lamiaceae Family Kazakhstani plants for potential production of tea beverages. Plants-Basel. (2021) 10. doi: 10.3390/plants10040666
135. Nair, AB, and Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. (2016) 7:27–31. doi: 10.4103/0976-0105.177703
136. Azhar, J, John, P, and Bhatti, A. Thymus serpyllum exhibits anti-diabetic potential in streptozotocin-induced diabetes mellitus type 2 mice: a combined biochemical and in vivo study. Nutrients. (2022) 14:3561. doi: 10.3390/nu14173561
137. Mihailovic-Stanojevic, N, Belscak-Cvitanovic, A, Grujic-Milanovic, J, Ivanov, M, Jovovic, D, Bugarski, D, et al. Antioxidant and antihypertensive activity of extract from Thymus serpyllum L. in experimental hypertension. Plant Foods Hum Nutr. (2013) 68:235–40. doi: 10.1007/s11130-013-0368-7
138. Algieri, F, Rodriguez-Nogales, A, Garrido-Mesa, N, Zorrilla, P, Burkard, N, Pischel, I, et al. Intestinal anti-inflammatory activity of the Serpylli herba extract in experimental models of rodent colitis. J Crohns Colitis. (2014) 8:775–88. doi: 10.1016/j.crohns.2013.12.012
139. Kolesnichenko, PD, Peresypkina, AA, Poromov, AA, Kareva, EN, Tverskoi, AV, and Demidenko, AN. Study to investigate the anti-inflammatory effect of Codelac® Broncho with Thymus Serpyllum (elixir) in comparison with reference drug Fenspiride (syrup) using accute carrageenan-induced paw inflammation model. Res Results Pharmacol. (2019) 5:45–52. doi: 10.3897/rrpharmacology.5.33233
140. Shaposhnikov, AA, Krut, UA, Gabruk, NG, Shentseva, EA, and Smalchenko, DE. Influence of phytomineral sorbents on metabolism change in inflammatory injury of rat tissue. Int J Pharm Technol. (2016) 8:14495–501.
141. Akhoondinasab, MR, Khodarahmi, A, Akhoondinasab, M, Saberi, M, and Iranpour, M. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment. Burns. (2015) 41:125–31. doi: 10.1016/j.burns.2014.04.001
142. Ruiz-Malagon, AJ, Rodriguez-Sojo, MJ, Hidalgo-Garcia, L, Molina-Tijeras, JA, Garcia, F, Pischel, I, et al. The antioxidant activity of Thymus serpyllum extract protects against the inflammatory state and modulates gut Dysbiosis in diet-induced obesity in mice. Antioxidants. (2022) 11:1073. doi: 10.3390/antiox11061073
143. Ruiz-Malagón, AJ, Rodríguez-Sanchez, MJ, Rodríguez-Sojo, MJ, Vezza, T, Pischel, I, Algieri, F, et al. Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats. Front Pharmacol. (2022) 13:967644. doi: 10.3389/fphar.2022.967644
144. Mendes, R, Sourgens, H, and Kemper, FH. Interaction of different plant ingredients with hypothalamic-hypophyseal hormones in the rat. Naunyn Schmiedeberg's Arch Pharmacol. (1980) 311
145. Sourgens, H, Winterhoff, H, Gumbinger, HG, and Kemper, FH. Effects of Lithospermum officinale and related plants on hypophyseal and thyroid hormones in the rat. Int J Crude Drug Res. (1986) 24:53–63. doi: 10.3109/13880208609083307
146. Knaub, K, Schön, C, Suarez, CG, and Pischel, I. Effects of a food supplement with a wild thyme (Thymus serpyllum L.) extract on gut health and the microbiome in humans: a randomized, double-blinded, placebo-controlled clinical trial. Food Nutr Sci. (2022) 13:931–49. doi: 10.4236/fns.2022.1311065
147. Food and Drug Administration . (n.d.) Thyme, Wild or Creeping, Extract (Thymus serpyllum L.). Available at: https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=FoodSubstances&id=THYMEWILDORCREEPINGEXTRACTTHYMUSSERPYLLUM (Accessed July 1, 2023).
148. Sertkaya, E . Fumigant toxicity of the essential oils from medicinal plants against bean weevil, Acanthoscelides obtectus (say) (Coleoptera: Bruchidae). Asian J Chem. (2013) 25:553–5. doi: 10.14233/ajchem.2013.13581
149. Jarić, S, Mačukanović-Jocić, M, Djurdjević, L, Mitrović, M, Kostić, O, Karadžić, B, et al. An ethnobotanical survey of traditionally used plants on Suva planina mountain (South-Eastern Serbia). J Ethnopharmacol. (2015) 175:93–108. doi: 10.1016/j.jep.2015.09.002
150. Oalde, MM, Kolarevic, SM, Zivkovic, JC, Vukovic-Gacic, BS, Maric, JMJ, Kolarevic, MJK, et al. The impact of different extracts of six Lamiaceae species on deleterious effects of oxidative stress assessed in acellular, prokaryotic and eukaryotic models in vitro. Saudi Pharmaceutical J. (2020) 28:1592–604. doi: 10.1016/j.jsps.2020.10.006
151. Joshi, T, and Juyal, V. Evaluation of antioxidant activity of some medicinal plants and their combination. Pharm J. (2021) 13:596–9. doi: 10.5530/pj.2021.13.75
152. Ateeq-ur-Rehman, A, Inayatullah, S, Akhtar, MZ, Qayyum, M, and Mirza, B. Biological evaluation of wild thyme (Thymus serpyllum). Pharm Biol. (2009) 47:628–33. doi: 10.1080/13880200902915622
Keywords: wild thyme, Thymus serpyllum, nutrition, health prevention, phytopharmacology, traditional use, gut-brain interaction, rosmarinic acid
Citation: Jalil B, Pischel I, Feistel B, Suarez C, Blainski A, Spreemann R, Roth-Ehrang R and Heinrich M (2024) Wild thyme (Thymus serpyllum L.): a review of the current evidence of nutritional and preventive health benefits*. Front. Nutr. 11:1380962. doi: 10.3389/fnut.2024.1380962
Edited by:
Eric Gumpricht, Isagenix International, LLC, United StatesReviewed by:
Mihai Babotă, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, RomaniaMarion Mackonochie, Pukka Herbs Ltd, United Kingdom
Copyright © 2024 Jalil, Pischel, Feistel, Suarez, Blainski, Spreemann, Roth-Ehrang and Heinrich. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Banaz Jalil, b.jalil@ucl.ac.uk; Ivo Pischel, i.pischel@ucl.ac.uk; Cynthia Suarez, cynthia.suarez-rizzo@finzelberg.com; Michael Heinrich, m.heinrich@ucl.ac.uk